Bryan Newman

2.2k total citations · 1 hit paper
33 papers, 1.8k citations indexed

About

Bryan Newman is a scholar working on Pharmaceutical Science, Pulmonary and Respiratory Medicine and Physiology. According to data from OpenAlex, Bryan Newman has authored 33 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Pharmaceutical Science, 14 papers in Pulmonary and Respiratory Medicine and 9 papers in Physiology. Recurrent topics in Bryan Newman's work include Inhalation and Respiratory Drug Delivery (14 papers), Advanced Drug Delivery Systems (9 papers) and Drug Solubulity and Delivery Systems (8 papers). Bryan Newman is often cited by papers focused on Inhalation and Respiratory Drug Delivery (14 papers), Advanced Drug Delivery Systems (9 papers) and Drug Solubulity and Delivery Systems (8 papers). Bryan Newman collaborates with scholars based in United States, United Kingdom and India. Bryan Newman's co-authors include Hasan Körkaya, Max S. Wicha, Shawn G. Clouthier, Duxin Sun, Sarah J. Conley, Yanke Yu, Amber Heath, Yanyan Li, Steven J. Schwartz and Tao Zhang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Cancer Research and Advanced Drug Delivery Reviews.

In The Last Decade

Bryan Newman

31 papers receiving 1.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Antiangiogenic agents increase breast cancer stem cells via the generation of tumor hypoxia

2012 521 citations Sarah J. Conley, Bryan Newman et al. profile →

Peers

Bryan Newman

ONCOL

CAM

Mysore S. Veena United States

Ling Xu China

Xuemei Huang China

Haigang Li China

Xiaoyu Chen China

Amareshwar T.K. Singh United States

Fang Zhou China

Guodong Li China

Ranjeet Prasad Dash United States

Linjiang Song China

Mysore S. Veena United States

Bryan Newman

944 ×1.1

308 ×0.6

ONCOL

327 ×0.8

98 ×0.4

67 ×0.4

CAM

Citations per year, relative to Bryan Newman Bryan Newman (= 1×) peers Mysore S. Veena

Countries citing papers authored by Bryan Newman

Since Specialization

Citations

This map shows the geographic impact of Bryan Newman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bryan Newman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bryan Newman more than expected).

Fields of papers citing papers by Bryan Newman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bryan Newman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bryan Newman. The network helps show where Bryan Newman may publish in the future.

Co-authorship network of co-authors of Bryan Newman

This figure shows the co-authorship network connecting the top 25 collaborators of Bryan Newman. A scholar is included among the top collaborators of Bryan Newman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bryan Newman. Bryan Newman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gong, Yuqing, Elizabeth Bielski, Venkateswaran C. Pillai, et al.. (2025). A 2024 Update on US FDA Implementation of Partial Area Under the Curve Into Bioavailability and Bioequivalence Assessments. Clinical Pharmacology & Therapeutics. 117(5). 1185–1193. 1 indexed citations

Shea, Katherine, Omnia A. Ismaiel, Murali K. Matta, et al.. (2025). Assessment of drug permeability using a small airway microphysiological system. Frontiers in Pharmacology. 16. 1621775–1621775.

Dutta, Rabijit, Arun V. Kolanjiyil, Ross Walenga, et al.. (2024). CFD-PK model for nasal suspension sprays: Validation with human adult in vivo data for triamcinolone acetonide. International Journal of Pharmaceutics. 665. 124660–124660. 3 indexed citations

Khadka, Prakash, Michael Hindle, Theodore A. Schuman, et al.. (2024). Anatomically-detailed segmented representative adult and pediatric nasal models for assessing regional drug delivery and bioequivalence with suspension nasal sprays. International Journal of Pharmaceutics. 666. 124743–124743. 3 indexed citations

Xu, Xiaoming, et al.. (2022). Cyclosporine release and distribution in ophthalmic emulsions determined by pulsatile microdialysis. International Journal of Pharmaceutics. 615. 121521–121521. 10 indexed citations

Wang, Zhong, et al.. (2022). Medication Cost-Savings and Utilization of Generic Inhaled Corticosteroid (ICS) and Long-Acting Beta-Agonist (LABA) Drug Products in the USA. Therapeutic Innovation & Regulatory Science. 56(2). 346–357. 5 indexed citations

Shur, Jagdeep, et al.. (2021). A Systematic Approach in the Development of the Morphologically-Directed Raman Spectroscopy Methodology for Characterizing Nasal Suspension Drug Products. The AAPS Journal. 23(4). 73–73. 6 indexed citations

Newman, Bryan, et al.. (2020). Addressing the Regulatory and Scientific Challenges with Generic Orally Inhaled Drug Products. Pharmaceutical Medicine. 34(2). 93–102. 20 indexed citations

Newman, Bryan, et al.. (2020). Influence of in vitro release methods on assessment of tobramycin ophthalmic ointments. International Journal of Pharmaceutics. 590. 119938–119938. 6 indexed citations

10.

Bao, Quanying, Bryan Newman, Yan Wang, Stephanie Choi, & Diane J. Burgess. (2018). In vitro and ex vivo correlation of drug release from ophthalmic ointments. Journal of Controlled Release. 276. 93–101. 58 indexed citations

11.

Newman, Bryan, Yan Wang, Stephanie Choi, et al.. (2018). Influence of Manufacturing Process Variables on the Properties of Ophthalmic Ointments of Tobramycin. Pharmaceutical Research. 35(9). 179–179. 20 indexed citations

12.

Ghosh, Priyanka, Bryan Newman, Dana C. Hammell, et al.. (2017). On the Road to Development of an in Vitro Permeation Test (IVPT) Model to Compare Heat Effects on Transdermal Delivery Systems: Exploratory Studies with Nicotine and Fentanyl. Pharmaceutical Research. 34(9). 1817–1830. 22 indexed citations

13.

Zhang, Qian, Michael Murawsky, Jinsong Hao, et al.. (2017). Characterization of Temperature Profiles in Skin and Transdermal Delivery System When Exposed to Temperature Gradients In Vivo and In Vitro. Pharmaceutical Research. 34(7). 1491–1504. 15 indexed citations

14.

Bao, Quanying, Jie Shen, Rajan Jog, et al.. (2017). In vitro release testing method development for ophthalmic ointments. International Journal of Pharmaceutics. 526(1-2). 145–156. 34 indexed citations

15.

Bao, Quanying, Rajan Jog, Jie Shen, et al.. (2017). Physicochemical attributes and dissolution testing of ophthalmic ointments. International Journal of Pharmaceutics. 523(1). 310–319. 37 indexed citations

16.

Raney, Sam G., et al.. (2016). Navigating sticky areas in transdermal product development. Journal of Controlled Release. 233. 1–9. 23 indexed citations

17.

Burnett, Joseph, Hasan Körkaya, Maria Ouzounova, et al.. (2015). Trastuzumab resistance induces EMT to transform HER2+ PTEN− to a triple negative breast cancer that requires unique treatment options. Scientific Reports. 5(1). 15821–15821. 54 indexed citations

18.

Burnett, Joseph, Bryan Newman, & Duxin Sun. (2012). Targeting Cancer Stem Cells with Natural Products. Current Drug Targets. 13(8). 1054–1064. 27 indexed citations

19.

Newman, Bryan, et al.. (2012). HSP90 Inhibitor 17-AAG Selectively Eradicates Lymphoma Stem Cells. Cancer Research. 72(17). 4551–4561. 57 indexed citations

20.

Li, Yanyan, Tao Zhang, Hasan Körkaya, et al.. (2010). Sulforaphane, a Dietary Component of Broccoli/Broccoli Sprouts, Inhibits Breast Cancer Stem Cells. Clinical Cancer Research. 16(9). 2580–2590. 443 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact